Efficacy of BNG-1 to Treat Acute Ischemic Stroke "BNG-1"

Completed

Phase 3 Results N/A

Summary of Purpose

The objective of this study is to investigate the efficacy and safety of BNG-1 in patients with ischemic stroke. The efficacy assessment will be based on the functional outcome while the safety will be reviewed by the adverse events and laboratory examinations.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 27 July 2015.

1 Aug 2012 2 Apr 2012 1 Nov 2014 1 Nov 2014 1 Jul 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • Tsong-Hai Lee, MD, PhD